Literature DB >> 185104

In vitro biosynthesis and release of three immuno-reactive insulin-like components by a human insulinoma.

D G Pipeleers, J Levy, F Malaisse-Lagae, W J Malaisse.   

Abstract

Pieces of a human insulinoma were incubated for 120 or 180 min in media containing labelled leucine. In addition to insulin and proinsulin, the tumoral tissue was found to synthesize and release a third immunoreactive insulin-like component of higher molecular weight. No significant amount of the latter component was detected in normal rat islets under identical experimental conditions. The rate of secretion of insulin-like peptides was abnormally high relative to their concentration in the tumoral tissue, and was apparently unaffected by various insulinotropic or inhibitory agents. Only cycloheximide was found to significantly reduce the synthesis and subsequent release of insulin-like peptides by the tumoral tissue. It is suggested that the secretion of large amounts of both the high molecular weight component and proinsulin relative to that of insulin might be due, in part at least, to the inability of the tumoral cells to prevent the release of newly synthetized hormonal peptides, leading to the depletion of the tissue in hormonal products, as judged by both immunological and ultrastructural criteria.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 185104

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  3 in total

1.  Insulinoma with hypoglycemia and normal immunoreactive insulin but with an insulin-like activity restricted to the portal vein.

Authors:  J Mirouze; G Marchal; A Orsetti; C Jaffiol; L Monnier; P Baldet; M Piperno; B Hedon
Journal:  Acta Diabetol Lat       Date:  1978 May-Aug

2.  Islet amyloid in Type 2 (non-insulin-dependent) diabetes is related to insulin.

Authors:  P Westermark; E Wilander
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

3.  Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.

Authors:  S D Garcia; C Jarrousse; G Rosselin
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.